Trial intelligence / Profile preview

Methylphenidate effects on acute pain dynamics

NCT05669924Phase 2Completed

Sponsor
Northwestern University
Start
Sep 2022
Primary completion
Apr 2024
Modality
Small Molecules
Countries
1
01

Overview

A Phase 2 trial of methylphenidate in acute pain, sponsored by Northwestern University. Started Sep 2022; status: completed.

02

Drugs

methylphenidate
03

Conditions

acute pain

Beyond the preview

Go deeper on NCT05669924.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT05669924.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call